[1] A. Jemal, F. Bray, M. M. Center et al.. Global cancer statistics[J]. CA Cancer J. Clin., 2011, 61(2): 69～90

[2] G. Almadori, F. Bussu, G. Cadoni et al.. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach[J]. European J. Cancer, 2005, 41(5): 683～693

[3] L. Ellis, B. Rachet, B. Birchall et al.. Trends and inequalities in laryngeal cancer survival in men and women: England and Wales 1991～2006[J]. Oral Oncology, 2012, 48(3): 284～289

[4] F. Islami, I. Tramacere, M. Rota et al.. Alcohol drinking and laryngeal cancer: overall and dose-risk relation—a systematic review and meta-analysis[J]. Oral Oncology, 2010, 46（11）: 802～810

[5] M. S. Cattaruzza, P. Maisonneuve, P. Boyle. Epidemiology of laryngeal cancer[J]. European J. Cancer Part B: Oral Oncology, 1996, 32(5): 293～305

[6] R. Khlifi, A. H. Chaffai. Head and neck cancer due to heavy metal exposure via tobacco smoking and professional exposure: a review[J]. Toxicology and Applied Pharmacology, 2010, 248(2): 71～88

[7] K. W. Mouwa, A. A. Solanki, K. M. Stenson et al.. Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy[J]. Oral Oncology, 2012, 48(10): 1025～1030

[8] R. R. Allison, R. E. Cuenca, G. H. Downie et al.. Clinical photodynamic therapy of head and neck cancers: a review of applications and outcomes[J]. Photodiagnosis and Photodynamic Therapy, 2005, 2(3): 205～222

[9] T. J. Dougherty, C. J. Gome, B. W. Henderson et al.. Photodynamic therapy [J]. J. National Cancer Institute, 1998, 90(12): 889～905

[10] 邹朝晖, 高平, 阴慧娟 等. 光动力疗法对人工龋口腔生物膜菌斑的影响[J] . 中国激光, 2009, 36(10): 2700～2704

    Zou Zhaohui, Gao Ping, Yin Huijuan et al.. Influence of photodynamic therapy on dental plaque of oral biofilm of artificial dental caries[J]. Chinese J. Lasers, 2009, 36(10): 2700～2704

[11] 张红雨, 马文江, 邹朝晖 等. 光动力法制备抗小鼠H22肝癌的肿瘤疫苗[J]. 中国激光, 2008, 35(4): 631～ 634

    Zhang Hongyu, Ma Wenjiang, Zou Zhaohui et al.. Generation of antitumor vaccines for H22 tumor on mouse using photodynamic therapy[J]. Chinese J. Lasers, 2008, 35( 4): 631～634

[12] 程刚, 钟秋海, 黄乃艳 等. 鲜红斑痣光动力治疗数学模型及临床验证[J]. 中国激光, 2006, 33(6): 857～862

    Cheng Gang, Zhong Qiuhai, Huang Naiyan et al.. Mathematics modeling and clinic experiment of photodynamic therapy for port wine stain[J]. Chinese J. Lasers, 2006, 33(6): 857～862

[13] 阴慧娟, 郑永唐, 李迎新 等. 光动力疗法抑制人免疫缺陷病毒复制的实验研究[J]. 中国激光, 2009, 36(10): 2705～2711

    Yin Huijuan, Zheng Yongtang, Li Yingxin et al.. Photochemical inactivation of cell-associated and cell-free human immunodeficiency virus in vitro[J] . Chinese J. Lasers, 2009, 36(10): 2705～2711

[14] A. A. Rosenkranz, D. A. Jans, A. S. Sobolev. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency[J]. Immunology and Cell Biology, 2000, 78(4): 452～464

[15] 石磊, 王秀丽, 王宏伟. 纳米粒载体在光动力治疗肿瘤中的应用[J]. 国际肿瘤学杂志, 2012, 39(3): 193～196

    Shi Lei, Wang Xiuli, Wang Hongwei. Application of nanoparticle vectors in photodynamic therapy of tumors[J]. J. International Oncology, 2012, 39(3): 193～196

[16] M. Afri, A. A. Frimer, Y. Cohen. Active oxygen chemistry within the liposomal bilayer. Part IV: locating 2′,7′-dichlorofluorescein (DCF), 2′,7′-dichlorodihydrofluorescein (DCFH) and 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) in the lipid bilayer[J]. Chemistry and Physics of Lipids, 2004, 131(1): 123～133

[17] A. P. Castano, T. N. Demidova, M. R. Hamblin. Mechanisms in photodynamic therapy. Part one: photosensitizers, photochemistry and cellular localization[J]. Photodiagnosis and Photodynamic Therapy, 2004, 1(4): 279～293

[18] T. H. Foster, R. S. Murant, R. G. Bryant et al.. Oxygen consumption and diffusion effects in photodynamic therapy[J]. Radiation Reseach, 1991, 126(3): 296～303

[19] J. Fuchs, J. Thiele. The role of oxygen in cutaneous photodynamic therapy[J]. Free Radic. Biol. Med, 1998, 24（5）: 835～847

[20] J. Moan, K. Berg. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen[J]. Photochemistry and Photobiology, 1991, 53(4): 549～553

[21] I. J. MacDonald, J. Morgan, D. A. Bellnier et al.. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide: a derivatives[J]. Photochemistry and Photobiology, 1999, 70(5): 789～797

[22] 戴维德, 李晓松, 曾晶 等. 光敏剂亚细胞分布位点光漂白作用的实验研究[J]. 中国激光医学杂志, 2007, 16(3): 137～141

    Dai Weide, Li Xiaosong, Zeng Jing et al.. Photobleaching of subcellular distributed sites of photosensitizers: an experimental study[J]. Chinese J. Laser Medicine & Surgery, 2007, 16(3): 137～141

[23] K. Berg, J. C. Bommer, J. W. Winkelman et al.. Cellular uptake and relative efficiency in cell inactivation by photoactivated sulfonated meso-tetraphenylporphines[J]. Photochemitry and Photobiology, 1990, 52(4): 775～781

[24] M. Dellinger. Apoptosis or necrosis following photofrin photosensitization: influence of the incubation protocol[J]. Photochemitry and Photobiology, 1996, 64(1): 182～187

[25] E. Buytaert, M. Dewaele, P. Agostinis. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy[J]. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2007, 1776(1): 86～107

[26] L. Duprez, E. Wirawan, T. V. Berghe et al.. Major cell death pathways at a glance[J]. Microbes and Infection, 2009, 11(13): 1050～1062

[27] M. T. Lin, M. F. Beal. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases[J]. Nature, 2006, 443（7113）: 787～795

[28] C. Nie, C. Tian, L. Zhao et al.. Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis[J]. The J. Biological Chemistry, 2008, 283（22）: 15359～15369

[29] F. Huang, C. Nie, Y. Yang et al.. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells[J]. Free Radic. Biol. Med., 2009, 46(8): 1186～1196